Preclinical Approaches to Examine Novel Concepts of the Pathophysiology of Depressive Disorders: Lessons Learned from Tree Shrews (Englisch)
- Neue Suche nach: Fuchs, E.
- Neue Suche nach: Czeh, B.
- Neue Suche nach: Flugge, G.
- Neue Suche nach: Fuchs, E.
- Neue Suche nach: Czeh, B.
- Neue Suche nach: Flugge, G.
- Neue Suche nach: Gurwitz, D.
- Neue Suche nach: Weizman, A.
In:
New Drug Targets for Depression and Anxiety Part II Focus on Peptides
4
;
309-317
;
2005
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Preclinical Approaches to Examine Novel Concepts of the Pathophysiology of Depressive Disorders: Lessons Learned from Tree Shrews
-
Beteiligte:Fuchs, E. ( Autor:in ) / Czeh, B. ( Autor:in ) / Flugge, G. ( Autor:in ) / Gurwitz, D. / Weizman, A.
-
Erschienen in:DRUG DEVELOPMENT RESEARCH ; 65, 4 ; 309-317
-
Verlag:
- Neue Suche nach: WILEY - LISS
-
Erscheinungsdatum:01.01.2005
-
Format / Umfang:9 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 615.19
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 615.19 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 65, Ausgabe 4
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 185
-
The involvement of neuropeptides in evolution, signaling, behavioral regulation and psychopathology: focus on vasopressinLandgraf, Rainer / Holsboer, Florian et al. | 2005
- 191
-
Can CRF1 receptor antagonists become antidepressant and/or anxiolytic agents?Overstreet, David H. / Knapp, Darin J. / Breese, George R. et al. | 2005
- 205
-
Homeostasis within the corticotropin‐releasing factor system via CRF2 receptor activation: a novel approach for the treatment of anxietyValdez, Glenn R. / Zorrilla, Eric P. / Koob, George F. et al. | 2005
- 216
-
NBI 30775 (R121919), an orally active antagonist of the corticotropin‐releasing factor (CRF) type‐1 receptor for the treatment of anxiety and depressionChen, Chen / Grigoriadis, Dimitri E. et al. | 2005
- 227
-
Galanin receptors as novel drug targets for the treatment of depression and anxietyLu, Xiaoying / Barr, Alasdair M. / Bartfai, Tamas et al. | 2005
- 237
-
Angiotensin II AT1 receptor antagonists inhibit the angiotensin‐CRF‐AVP axis and are potentially useful for the treatment of stress‐related and mood disordersSaavedra, Juan M. / Pavel, Jaroslav et al. | 2005
- 270
-
The brain renin–angiotensin system: a target for novel antidepressants and anxiolyticsGard, Paul R. et al. | 2005
- 278
-
Melanin‐concentrating hormone receptor 1 antagonists for the treatment of depression and anxietyChaki, Shigeyuki / Yamaguchi, Jun‐ichi / Yamada, Hisaharu / Kanuma, Kosuke / Sekiguchi, Yoshinori et al. | 2005
- 291
-
Small molecule melanin‐concentrating hormone receptor 1 (MCH1R) antagonists as anxiolytic and antidepressive agentsDyck, Brian et al. | 2005
- 301
-
Neuropeptide Y receptors as therapeutic targets in anxiety and depressionSajdyk, Tammy J. et al. | 2005
- 309
-
Preclinical approaches to examine novel concepts of the pathophysiology of depressive disorders: lessons learned from tree shrewsFuchs, Eberhard / Czéh, Boldizsár / Flügge, Gabriele et al. | 2005
- 318
-
Potential use of neurosteroids and neuroactive steroids as modulators of symptoms of depression, anxiety, and psychotic disordersDubrovsky, Bernardo et al. | 2005
- 335
-
Remission and recovery in depression treatmentTrivedi, Madhukar H. / Kleiber, Beverly / Greer, Tracy L. et al. | 2005